| Lakewood Health System Hospice 401 East Prairie Avenue, Staples, MN, 56479 | |
| (218) 894-8080 |
News Archive
New data shows Shady Grove Fertility Center's financial programs - designed to help make infertility testing and treatment more affordable - helped more than a quarter of patients proceed with treatment in 2010, despite the year's significant economic challenges.
Research findings provide direct evidence that people with chronic diseases are more likely to be food insecure - that is suffering from inadequate, insecure access to food as a result of financial constraints.
SMT Research and Development, Ltd., a privately held company, announced that it has completed its first two clinical cases using the Shimon Embolic Filter [SHEF] (TM). SMT R&D developed a novel technology for brain protection (Neuroprotection) from stroke complication hazards arising from invasive cardiology procedures and heart surgery.
BioMarin Pharmaceutical Inc. announced today that Genzyme notified the company that, in rare circumstances, it has detected foreign particles in some products filled at the Allston Landing facility. To ensure that patients are not exposed to foreign particles during product administration, Genzyme has issued a "Dear Doctor" letter to all physicians treating patients with enzyme replacement products that it markets, including Aldurazyme.
Cerus Corporation announced today that the FDA's Blood Products Advisory Committee (BPAC) rendered a positive opinion on the proposed hemostatic efficacy and safety endpoints for a potential U.S. Phase III clinical trial of the INTERCEPT Blood System for platelets.
› Verified 5 days ago
| Name | Lakewood Health System Hospice |
|---|---|
| Location | 401 East Prairie Avenue, Staples, Minnesota |
| Hospice ID | 241559 |
| Category | Part of a hospital |
| Ownership Type | Voluntary Non-profit - Other |
| Profit Type | NON-PROFIT |
| SSA county code | 760 |
News Archive
New data shows Shady Grove Fertility Center's financial programs - designed to help make infertility testing and treatment more affordable - helped more than a quarter of patients proceed with treatment in 2010, despite the year's significant economic challenges.
Research findings provide direct evidence that people with chronic diseases are more likely to be food insecure - that is suffering from inadequate, insecure access to food as a result of financial constraints.
SMT Research and Development, Ltd., a privately held company, announced that it has completed its first two clinical cases using the Shimon Embolic Filter [SHEF] (TM). SMT R&D developed a novel technology for brain protection (Neuroprotection) from stroke complication hazards arising from invasive cardiology procedures and heart surgery.
BioMarin Pharmaceutical Inc. announced today that Genzyme notified the company that, in rare circumstances, it has detected foreign particles in some products filled at the Allston Landing facility. To ensure that patients are not exposed to foreign particles during product administration, Genzyme has issued a "Dear Doctor" letter to all physicians treating patients with enzyme replacement products that it markets, including Aldurazyme.
Cerus Corporation announced today that the FDA's Blood Products Advisory Committee (BPAC) rendered a positive opinion on the proposed hemostatic efficacy and safety endpoints for a potential U.S. Phase III clinical trial of the INTERCEPT Blood System for platelets.
› Verified 5 days ago
| NPI Number | 1922099092 |
| Organization Name | Lakewood Health System |
| Address | 401 Prairie Ave Ne Staples, Minnesota, 56479 |
| Phone Number | (218)894-1515 |
News Archive
New data shows Shady Grove Fertility Center's financial programs - designed to help make infertility testing and treatment more affordable - helped more than a quarter of patients proceed with treatment in 2010, despite the year's significant economic challenges.
Research findings provide direct evidence that people with chronic diseases are more likely to be food insecure - that is suffering from inadequate, insecure access to food as a result of financial constraints.
SMT Research and Development, Ltd., a privately held company, announced that it has completed its first two clinical cases using the Shimon Embolic Filter [SHEF] (TM). SMT R&D developed a novel technology for brain protection (Neuroprotection) from stroke complication hazards arising from invasive cardiology procedures and heart surgery.
BioMarin Pharmaceutical Inc. announced today that Genzyme notified the company that, in rare circumstances, it has detected foreign particles in some products filled at the Allston Landing facility. To ensure that patients are not exposed to foreign particles during product administration, Genzyme has issued a "Dear Doctor" letter to all physicians treating patients with enzyme replacement products that it markets, including Aldurazyme.
Cerus Corporation announced today that the FDA's Blood Products Advisory Committee (BPAC) rendered a positive opinion on the proposed hemostatic efficacy and safety endpoints for a potential U.S. Phase III clinical trial of the INTERCEPT Blood System for platelets.
› Verified 5 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 97.6 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 90.9 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 98.8 | 97.3 |
| Patients who got timely treatment for shortness of breath | 96.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 94.4 | 93.3 |
News Archive
New data shows Shady Grove Fertility Center's financial programs - designed to help make infertility testing and treatment more affordable - helped more than a quarter of patients proceed with treatment in 2010, despite the year's significant economic challenges.
Research findings provide direct evidence that people with chronic diseases are more likely to be food insecure - that is suffering from inadequate, insecure access to food as a result of financial constraints.
SMT Research and Development, Ltd., a privately held company, announced that it has completed its first two clinical cases using the Shimon Embolic Filter [SHEF] (TM). SMT R&D developed a novel technology for brain protection (Neuroprotection) from stroke complication hazards arising from invasive cardiology procedures and heart surgery.
BioMarin Pharmaceutical Inc. announced today that Genzyme notified the company that, in rare circumstances, it has detected foreign particles in some products filled at the Allston Landing facility. To ensure that patients are not exposed to foreign particles during product administration, Genzyme has issued a "Dear Doctor" letter to all physicians treating patients with enzyme replacement products that it markets, including Aldurazyme.
Cerus Corporation announced today that the FDA's Blood Products Advisory Committee (BPAC) rendered a positive opinion on the proposed hemostatic efficacy and safety endpoints for a potential U.S. Phase III clinical trial of the INTERCEPT Blood System for platelets.
› Verified 5 days ago
| Home Health Aides | 1 |
| Counselors | 0.5 |
| Homemakers | 0.5 |
| Medical Social Workers | 1.25 |
| Physicians | 0.25 |
| Registered Nurses | 1.25 |
| Total Employees | 4.75 |
|---|
News Archive
New data shows Shady Grove Fertility Center's financial programs - designed to help make infertility testing and treatment more affordable - helped more than a quarter of patients proceed with treatment in 2010, despite the year's significant economic challenges.
Research findings provide direct evidence that people with chronic diseases are more likely to be food insecure - that is suffering from inadequate, insecure access to food as a result of financial constraints.
SMT Research and Development, Ltd., a privately held company, announced that it has completed its first two clinical cases using the Shimon Embolic Filter [SHEF] (TM). SMT R&D developed a novel technology for brain protection (Neuroprotection) from stroke complication hazards arising from invasive cardiology procedures and heart surgery.
BioMarin Pharmaceutical Inc. announced today that Genzyme notified the company that, in rare circumstances, it has detected foreign particles in some products filled at the Allston Landing facility. To ensure that patients are not exposed to foreign particles during product administration, Genzyme has issued a "Dear Doctor" letter to all physicians treating patients with enzyme replacement products that it markets, including Aldurazyme.
Cerus Corporation announced today that the FDA's Blood Products Advisory Committee (BPAC) rendered a positive opinion on the proposed hemostatic efficacy and safety endpoints for a potential U.S. Phase III clinical trial of the INTERCEPT Blood System for platelets.
› Verified 5 days ago
| Lakewood Health System Hospice Location: 401 East Prairie Avenue, Staples, Minnesota, 56479 Phone: (218) 894-8080 |